References
- CEMACH. Confidential Enquiry into Maternal and Child Health. Pregnancy in women with type 1 and type 2 diabetes in 2002-03, England, Wales and Northern Ireland. London; 2005
- Department of Health. National Health Service 2005–2006 Reference Costs. Available at:http://www.dh.gov.uk/en/Policyandguidance/Organisationpolicy/Financeandplanning/NHSreferencecosts/index.htm.Accessed Oct 2007
- Mathiesen ER, Kinsley B, Amiel SA, et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007;30:771-6
- Hod M, Damm P, Kaaja R, et al. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2007;198:186-7
- American Diabetes Association. Preconception care of women with diabetes. Diabetes Care 2002;25:82-84
- Office of National Statistics. CPI Annual Percentage Change 1988–2007. Available at: http://www.statistics.gov.uk/statbase/tsdtables1.asp?vlnk=mm23. Accessed Oct 2007
- Langhoff-Roos J, Kesmodel U, Jacobsson B, et al. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study. BMJ 2006;332:937-9
- Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-40
- National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. Available at: http://www.nice.org.uk/niceMedia/pdf/TAP_Methods.pdf. Accessed 22 May 2008
- Nicholson WK, Fleisher LA, Fox HE, et al. Screening for gestational diabetes mellitus: a decision and cost-effectiveness analysis of four screening strategies. Diabetes Care 2005;28:1482-4
- National Institute for Health and Clinical Excellence. CG63 Diabetes in pregnancy: NICE guidance. Available at: http://www.nice.org.uk/nicemedia/pdf/CG063FullGuidance.pdf. Accessed 22 May 2008
- Elixhauser A, Weschler JM, Kitzmiller JL, et al. Cost-benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care 1993;16:1146-57
- Odibo AO, Coassolo KM, Stamilio DM, et al. Should all pregnant diabetic women undergo a fetal echocardiography? A cost-effectiveness analysis comparing four screening strategies. Prenat Diagn 2006;26:39-44
- Lepercq J, Coste J, Theau A, et al. Factors associated with preterm delivery in women with type 1 diabetes: a cohort study. Diabetes Care 2004;27:2824-8
- Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004;328:915
- Herman WH, Janz NK, Becker MP, et al. Diabetes and pregnancy. Preconception care, pregnancy outcomes, resource utilization and costs. J Reprod Med 1999;44:33-8
- British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary. Available at: www.bnf.org.uk. Accessed Oct 2007